Edition:
United Kingdom

Chiasma Inc (CHMA.OQ)

CHMA.OQ on NASDAQ Stock Exchange Global Select Market

3.98USD
21 Feb 2019
Change (% chg)

-- (--)
Prev Close
$3.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
15,628
52-wk High
$4.81
52-wk Low
$1.20

Chart for

About

Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial... (more)

Overall

Beta: --
Market Cap(Mil.): $70.64
Shares Outstanding(Mil.): 24.36
Dividend: --
Yield (%): --

Financials

  CHMA.OQ Industry Sector
P/E (TTM): -- 30.48 33.70
EPS (TTM): -1.28 -- --
ROI: -34.47 14.95 14.45
ROE: -35.41 16.27 15.96

Earnings vs. Estimates